382 related articles for article (PubMed ID: 7574046)
1. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
[TBL] [Abstract][Full Text] [Related]
2. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
Huyzen RJ; Harder MP; Huet RC; Boonstra PW; Brenken U; van Oeveren W
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
[TBL] [Abstract][Full Text] [Related]
3. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
4. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
Feindt P; Seyfert UT; Volkmer I; Straub U; Gams E
Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
[TBL] [Abstract][Full Text] [Related]
5. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
De Vries AJ; Lansink-Hartgring AO; Fernhout FJ; Huet RCG; van den Heuvel ER
Interact Cardiovasc Thorac Surg; 2017 Apr; 24(4):549-554. PubMed ID: 28108578
[TBL] [Abstract][Full Text] [Related]
6. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
Wendel HP; Heller W; Gallimore MJ; Bantel H; Müller-Beissenhirtz H; Hoffmeister HE
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
Despotis GJ; Filos KS; Levine V; Alsoufiev A; Spitznagel E
Anesth Analg; 1996 Jun; 82(6):1126-31. PubMed ID: 8638779
[TBL] [Abstract][Full Text] [Related]
8. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
9. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
10. Effects of low doses of aprotinin on clotting times activated with celite and kaolin.
Farooqi N; De Hert S; Vlaeminck R; De Bakker A; Govaerts E; Vermeyen K
Acta Anaesthesiol Belg; 1993; 44(3):87-92. PubMed ID: 7508668
[TBL] [Abstract][Full Text] [Related]
11. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
12. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations.
Dietrich W; Schöpf K; Spannagl M; Jochum M; Braun SL; Meisner H
Ann Thorac Surg; 1998 Jan; 65(1):70-7; discussion 77-8. PubMed ID: 9456098
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin.
Wang JS; Lin CY; Hung WT; Karp RB
Anesthesiology; 1992 Dec; 77(6):1080-4. PubMed ID: 1281624
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
[TBL] [Abstract][Full Text] [Related]
15. Aprotinin does not prolong the Sonoclot aprotinin-insensitive activated clotting time.
Dong Y; Nuttall GA; Oliver WC; Agarwal S; Ereth MH
J Clin Anesth; 2007 Sep; 19(6):424-8. PubMed ID: 17967670
[TBL] [Abstract][Full Text] [Related]
16. Activated clotting time, anticoagulation, use of heparin, and thrombin activation during extracorporeal circulation: changes under aprotinin therapy.
Feindt P; Volkmer I; Seyfert U; Huwer H; Kalweit G; Gams E
Thorac Cardiovasc Surg; 1993 Feb; 41(1):9-15. PubMed ID: 7690165
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
Swartz MF; Fink GW; Searles B
J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
[TBL] [Abstract][Full Text] [Related]
20. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement.
Machin D; Devine P
J Extra Corpor Technol; 2005 Sep; 37(3):265-71. PubMed ID: 16350378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
